Assessing racial/ethnic disparities in chemotherapy treatment among breast cancer patients in context of changing treatment guidelines
about
Patterns of 21-gene assay testing and chemotherapy use in black and white breast cancer patients.Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities.Symptom incidence, distress, cancer-related distress, and adherence to chemotherapy among African American women with breast cancer.Influence of provider factors and race on uptake of breast cancer gene expression profiling.Breast cancer survival, survival disparities, and guideline-based treatment.
P2860
Assessing racial/ethnic disparities in chemotherapy treatment among breast cancer patients in context of changing treatment guidelines
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Assessing racial/ethnic dispar ...... changing treatment guidelines
@en
Assessing racial/ethnic dispar ...... changing treatment guidelines.
@nl
type
label
Assessing racial/ethnic dispar ...... changing treatment guidelines
@en
Assessing racial/ethnic dispar ...... changing treatment guidelines.
@nl
prefLabel
Assessing racial/ethnic dispar ...... changing treatment guidelines
@en
Assessing racial/ethnic dispar ...... changing treatment guidelines.
@nl
P2093
P2860
P1476
Assessing racial/ethnic dispar ...... changing treatment guidelines
@en
P2093
Carol Estwing Ferrans
Garth H Rauscher
Kent Hoskins
P2860
P2888
P304
P356
10.1007/S10549-013-2759-8
P407
P577
2013-11-22T00:00:00Z